BWM
AUPH icon

BCS Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

BCS Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Sell
12,083
-12,083
-50% -$177K 0.04% 247
2025
Q4 		$385K Buy
24,166
+11,996
+99% +$170K 0.04% 254
2025
Q3 		$134K Hold
12,170
– – 0.03% 246
2025
Q2 		$103K Hold
12,170
– – 0.02% 263
2025
Q1 		$98K Hold
12,170
– – 0.03% 243
2024
Q4 		$109K Hold
12,170
– – 0.03% 255
2024
Q3 		$89K Hold
12,170
– – 0.04% 167
2024
Q2 		$69K Hold
12,170
– – 0.03% 155
2024
Q1 		$61K Hold
12,170
– – 0.02% 235
2023
Q4 		$109K Hold
12,170
– – 0.04% 219
2023
Q3 		$95K Hold
12,170
– – 0.04% 198
2023
Q2 		$118K Buy
+12,170
New +$126K 0.09% 113
2023
Q1 		– Sell
-11,170
Closed -$48K – 163
2022
Q4 		$48K Buy
11,170
+1,000
+10% +$5.8K 0.02% 189
2022
Q3 		$76K Buy
+10,170
New +$88K 0.04% 176

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return